The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Highly sensitive determination of PIK3CA exon 9 and 20 hotspot mutations in breast tumors.
Alexandre Harle
No relevant relationships to disclose
Nicolas Lozano
No relevant relationships to disclose
Cyrielle Nicolaizeau
No relevant relationships to disclose
Maeva Lion
No relevant relationships to disclose
Marie Husson
No relevant relationships to disclose
Marie Rouyer
No relevant relationships to disclose
Carole Ramacci
No relevant relationships to disclose
Pascal Genin
No relevant relationships to disclose
Jean-Louis Merlin
No relevant relationships to disclose